ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

NIH Biennial Report Offers Research Portrait

September 24, 2010

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000